XYWAV (calcium, magnesium, potassium, and sodium oxybates)
**Product type:** Human Prescription Drug
**Active ingredient:** CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE
**Strength:** .5; .5; .5; .5 g/mL; g/mL; g/mL; g/mL
**Dosage form:** Solution
**Route:** Oral
**Labeler:** Jazz Pharmaceuticals, Inc.
**Marketing category:** NDA (NDA212690)
**Pharmacologic class:** Central Nervous System Depressant [EPC], Central Nervous System Depressant [EPC], Central Nervous System Depressant [EPC], Central Nervous System Depressant [EPC], Central Nervous System Depression [PE], Central Nervous System Depression [PE], Central Nervous System Depression [PE], Central Nervous System Depression [PE], Decreased Central Nervous System Organized Electrical Activity [PE], Decreased Central Nervous System Organized Electrical Activity [PE], Decreased Central Nervous System Organized Electrical Activity [PE], Decreased Central Nervous System Organized Electrical Activity [PE]
**DEA schedule:** CIII
/api/v1/systems/ndc_fda/nodes/68727-150Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.